Fig. 3From: SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemicDifference in seroconversion between group A (solid red line) and group B (solid blue line); p < 0.01. Analysis includes only patients with CT findings compatible with a high level of certainty for COVID-19Back to article page